Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katila

Showing results (361-370 of 372) with videos related to

Pageof 38
Sort By:
Journal of Neurotrauma|November 30, 2018
Early Levels of Glial Fibrillary Acidic Protein and Neurofilament Light Protein in Predicting the Outcome of Mild Traumatic Brain InjuryIftakher Hossain, Mehrbod Mohammadian, Riikka S K Takala, et al.
Journal of Neurotrauma|June 28, 2018
Serum Metabolites Associated with Computed Tomography Findings after Traumatic Brain InjuryAlex M Dickens, Jussi P Posti, Riikka S K Takala, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosisEmma C Tallantyre, Martin J Scurr, Nicola Vickaryous, et al.
Ebiomedicine|September 26, 2016
Human Serum Metabolites Associate With Severity and Patient Outcomes in Traumatic Brain InjuryMatej Orešič, Jussi P Posti, Maja H Kamstrup-Nielsen, et al.
Frontiers in Neurology|November 16, 2020
Admission Levels of Interleukin 10 and Amyloid β 1-40 Improve the Outcome Prediction Performance of the Helsinki Computed Tomography Score in Traumatic Brain InjuryJussi P Posti, Riikka S K Takala, Rahul Raj, et al.
Journal of Neurotrauma|February 15, 2019
Correlation of Blood Biomarkers and Biomarker Panels with Traumatic Findings on Computed Tomography after Traumatic Brain InjuryJussi P Posti, Riikka S K Takala, Linnéa Lagerstedt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccinationSafiya A Zaloum, Callum H Wood, Pooja Tank, et al.
Multiple Sclerosis and Related Disorders|May 31, 2022
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)Ruth Dobson, Matthew Craner, Ed Waddingham, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 18, 2024
A multi-institutional study to investigate the sparing effect after whole brain electron FLASH in mice: Reproducibility and temporal evolution of functional, electrophysiological, and neurogenic endpointsOlivia G G Drayson, Stavros Melemenidis, Nikita Katila, et al.
Annals of Neurology|October 23, 2021
COVID-19 Vaccine Response in People with Multiple SclerosisEmma C Tallantyre, Nicola Vickaryous, Valerie Anderson, et al.
Pageof 38

Showing results (361-370 of 372) with videos related to

Sort By:
Pageof 38
Journal of Neurotrauma|November 30, 2018
Early Levels of Glial Fibrillary Acidic Protein and Neurofilament Light Protein in Predicting the Outcome of Mild Traumatic Brain InjuryIftakher Hossain, Mehrbod Mohammadian, Riikka S K Takala, et al.
Journal of Neurotrauma|June 28, 2018
Serum Metabolites Associated with Computed Tomography Findings after Traumatic Brain InjuryAlex M Dickens, Jussi P Posti, Riikka S K Takala, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosisEmma C Tallantyre, Martin J Scurr, Nicola Vickaryous, et al.
Ebiomedicine|September 26, 2016
Human Serum Metabolites Associate With Severity and Patient Outcomes in Traumatic Brain InjuryMatej Orešič, Jussi P Posti, Maja H Kamstrup-Nielsen, et al.
Frontiers in Neurology|November 16, 2020
Admission Levels of Interleukin 10 and Amyloid β 1-40 Improve the Outcome Prediction Performance of the Helsinki Computed Tomography Score in Traumatic Brain InjuryJussi P Posti, Riikka S K Takala, Rahul Raj, et al.
Journal of Neurotrauma|February 15, 2019
Correlation of Blood Biomarkers and Biomarker Panels with Traumatic Findings on Computed Tomography after Traumatic Brain InjuryJussi P Posti, Riikka S K Takala, Linnéa Lagerstedt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccinationSafiya A Zaloum, Callum H Wood, Pooja Tank, et al.
Multiple Sclerosis and Related Disorders|May 31, 2022
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)Ruth Dobson, Matthew Craner, Ed Waddingham, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 18, 2024
A multi-institutional study to investigate the sparing effect after whole brain electron FLASH in mice: Reproducibility and temporal evolution of functional, electrophysiological, and neurogenic endpointsOlivia G G Drayson, Stavros Melemenidis, Nikita Katila, et al.
Annals of Neurology|October 23, 2021
COVID-19 Vaccine Response in People with Multiple SclerosisEmma C Tallantyre, Nicola Vickaryous, Valerie Anderson, et al.
Pageof 38